BM
Brett Matthew Hall bought $25K of IMRX stock
Brett Matthew Hall, Chief Scientific Officer of Immuneering Corp (IMRX), bought 6,035 shares of IMRX stock worth $25K, per an SEC Form 4 filed Jun 16, 2026.
It was an open-market purchase.
The trade happened on Jun 15, 2026, 1 day before it was made public.
IMRX has moved -17.7% since the trade date, from $4.19 to $3.45 (Nov 19, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 16, 2026
- Filing delay
- 1 day
- Price since
- -17.7%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4